Scarica l'app Stockscreener
172.84
1.38%
-2.3144
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DHR Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$175.15
Aprire:
$174.62
Volume 24 ore:
1.71M
Relative Volume:
0.39
Capitalizzazione di mercato:
$122.26B
Reddito:
$24.78B
Utile/perdita netta:
$3.68B
Rapporto P/E:
33.40
EPS:
5.1743
Flusso di cassa netto:
$5.29B
1 W Prestazione:
-4.37%
1M Prestazione:
-9.62%
6M Prestazione:
-19.22%
1 anno Prestazione:
-13.23%
Intervallo 1D:
$172.56
$175.54
Intervallo di 1 settimana:
$172.56
$183.00
Portata 52W:
$172.56
$242.80
Danaher Corp Stock (DHR) Company Profile
Nome
Danaher Corp
Settore
Industria
Telefono
(202) 828-0850
Indirizzo
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, A, NTRA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
172.75 | 123.97B | 24.78B | 3.68B | 5.29B | 5.1743 |
TMO
Thermo Fisher Scientific Inc
|
463.34 | 174.37B | 45.20B | 6.87B | 6.75B | 18.19 |
IDXX
Idexx Laboratories Inc
|
555.68 | 45.07B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
112.12 | 32.36B | 7.07B | 1.29B | 993.00M | 4.5355 |
NTRA
Natera Inc
|
207.88 | 29.60B | 2.31B | -208.16M | 76.11M | -1.5366 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-03-14 | Aggiornamento | Stifel | Hold → Buy |
| 2025-02-03 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2024-12-13 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-31 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Iniziato | HSBC Securities | Hold |
| 2023-12-13 | Ripresa | Wolfe Research | Peer Perform |
| 2023-12-07 | Downgrade | Goldman | Buy → Neutral |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-05-01 | Iniziato | SVB Securities | Outperform |
| 2023-04-26 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-04-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-10-24 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-08-17 | Ripresa | Bernstein | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-06-01 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Iniziato | Bernstein | Outperform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-10 | Reiterato | BofA Securities | Buy |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-23 | Reiterato | Goldman | Buy |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-04-07 | Ripresa | Robert W. Baird | Outperform |
| 2021-03-03 | Ripresa | Barclays | Overweight |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Ripresa | Stifel | Hold |
| 2019-10-28 | Reiterato | Needham | Buy |
| 2019-10-14 | Ripresa | Credit Suisse | Outperform |
| 2019-07-19 | Reiterato | Needham | Buy |
| 2019-06-11 | Iniziato | Piper Jaffray | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-04-17 | Reiterato | Needham | Buy |
| 2019-02-28 | Reiterato | Needham | Buy |
| 2019-02-25 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-03 | Iniziato | Needham | Buy |
| 2018-04-20 | Reiterato | Stifel | Buy |
Mostra tutto
Danaher Corp Borsa (DHR) Ultime notizie
Masimo shareholders give green light to $10B acquisition by Danaher - MassDevice
Masimo (NASDAQ: MASI) shareholders back $180 cash acquisition by Danaher - Stock Titan
Investors Can Find Comfort In Danaher's (NYSE:DHR) Earnings Quality - Yahoo Finance
Danaher Corp. stock underperforms Friday when compared to competitors - MarketWatch
Masimo (MASI) 10-K/A adds governance, CEO pay terms and Danaher merger plans - Stock Titan
[144] DANAHER CORP /DE/ SEC Filing - Stock Titan
Danaher Corporation stock hits 52-week low at $174.97 By Investing.com - Investing.com UK
Danaher Corporation stock hits 52-week low at $174.97 - Investing.com
DHR Stock Price, Quote & Chart | DANAHER CORP (NYSE:DHR) - ChartMill
Danaher Corp. may be the smartest bet in biotech right now - MSN
Single-use Bioprocessing Market Size Advancing at 11.0% CAGR | - openPR.com
Danaher Corporation: China Headwinds Persist—But Is the Core Business Strong Enough to Offset? - Smartkarma
Danaher Corp. Stock (US2358511028): Q1 2026 Earnings Set for Release Today - AD HOC NEWS
Danaher Corporation (DHR) Announces Issuance of €3 Billion in Se - GuruFocus
Danaher Corp (DHR) Stock Price, Trades & News - GuruFocus
Vanguard reports 47.4M-share stake in Danaher (NYSE: DHR) via 13G - Stock Titan
€2.98B Danaher (NYSE: DHR) euro notes to support Masimo acquisition - Stock Titan
Danaher posts $6B quarter and raises 2026 profit outlook - Stock Titan
Is It Time To Reassess Danaher (DHR) After Recent Share Price Weakness - simplywall.st
Danaher Q1 earnings beat estimates, life sciences sales up Y/Y - MSN
Danaher to buy medical tech firm Masimo for $9.9 billion - MSN
[Latest] Global Cell Culture Media Bags Market Size/Share Worth USD 2.28 Billion by 2035 at a 5.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Danaher (NYSE: DHR) director granted 231.809 phantom shares - Stock Titan
Danaher (NYSE: DHR) director defers fees into 17.248 phantom share units - Stock Titan
Danaher (NYSE: DHR) director awarded new phantom share units - Stock Titan
Danaher (DHR) director Linda Filler adds 20.121 phantom shares in deferred award - Stock Titan
Danaher (NYSE: DHR) director adds 252 phantom shares via deferred fees - Stock Titan
Danaher (NYSE: DHR) director receives 187.894 phantom share award - Stock Titan
Bulk Filtration Market Report 2026, Competitive Analysis of 3M, Eaton, Parker-Hannifin, Pentair, Merck, Danaher, Mann+Hummel - GlobeNewswire Inc.
Former Fortive CEO who led $16B-to-$25B rise joins CD&R - Stock Titan
Point of Care Diagnostics Market | Abbott Laboratories, BD, Danaher Corp, Nova Biomedical Corporation etc. - openPR.com
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
XS335208480 Bond Analysis — Key Metrics - TradingView
XS335208340 Bond Analysis — Key Metrics - TradingView
Danaher Stock Forecast: What Is Driving Market Focus - Kalkine Media
State of Michigan Retirement System Decreases Holdings in Danaher Corporation $DHR - MarketBeat
Danaher said to near $10 billion deal for Masimo, FT reports - MSN
Advisors Capital Management LLC Has $12.56 Million Stock Position in Danaher Corporation $DHR - MarketBeat
5 New 5-Star Stocks This Week - Morningstar
Danaher Corp. stock underperforms Wednesday when compared to competitors - MSN
Danaher Corp. stock (US2358511028): Why Google Discover changes matter more now - AD HOC NEWS
Biotech Stocks To Keep An Eye OnApril 26th - MarketBeat
Vanguard Group Inc. Has $13.96 Billion Position in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Purchased by AEGON ASSET MANAGEMENT UK Plc - MarketBeat
Danaher (NYSE:DHR) Falls After Argus Cut, S&P 500 Outlook Mixed - Kalkine Media
Danaher deal finalized: Company to acquire Masimo for $9.9 billion in cash - MSN
Danaher Corporation (DHR) Reports Q1 Adjusted EPS Beat - Insider Monkey
Argus Issues Pessimistic Forecast for Danaher (NYSE:DHR) Stock Price - MarketBeat
Impax Asset Management Group plc Sells 51,641 Shares of Danaher Corporation $DHR - MarketBeat
This Stock Is Up Over 52,700% Since Founding. Should Investors Buy After Its 36% Decline? - AOL.com
Danaher Corporation $DHR is Montrusco Bolton Investments Inc.'s 6th Largest Position - MarketBeat
Danaher Corp Azioni (DHR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.15%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):